As mentioned above, there are significant differences in the expression levels of RBM proteins in lung cancer, breast cancer, liver cancer, colon cancer, and other human cancers, and their expression levels are significantly correlated with prognosis. This evidence concerns the gene RBMY1A1 and lung carcinoma.